Our Services
Oncology Reimbursement Management (ORM) provides consulting and research services to help determine whether oncology products are positioned for maximum success with key access and reimbursement payers, providers, distributors and other stakeholders.
Our highly specialized services are focused exclusively on oncology market access, primarily in service to bio-pharmaceutical clients throughout the U.S., partnering with them to devise solutions for the increasingly complex healthcare environment. We apply deep marketplace knowledge and decades of first-hand industry experience to help our clients interpret key insights and translate these findings into actionable strategies that drive results. Together with our clients, we work to ensure cancer patients have access to appropriate, innovative treatments that advance care and save lives.
Syndicated Reports
In-depth, multi-client reports that provide important perspectives of the oncology landscape.
- Oncology Account Manager Report: Measures the effectiveness and performance of Oncology Account Managers across 22 leading pharmaceutical and biotech companies; respondents include CAC members, state society leaders and payer medical and pharmacy directors
- Institutional Pathway Report: Includes 70+ institutions with outpatient cancer services, focusing on NCCN, NCI-designated cancer centers, IDNs, ACOs and additional academic and community institutions (Published bi-annually)
- Oncology Outpatient Marketplace Management Report: Includes 70 institutions and 25 large community-based practices with outpatient cancer services and focuses on cancer drug treatment controls and treatment decision systems as well as change-drivers
Consulting
Customized, client-specific projects for pre- and post-launch phases to support mobilization and access.
- Landscape assessment
- Market access strategy
- Pricing and distribution solutions
- Launch mobilization
- Contracting and rebating
- Value propositions
- Formulary access and utilization management
Research
Thoughtful, targeted investigations designed to uncover actionable insights.
- Qualitative research: Customized surveys to address key business questions
- Quantitative research: In-depth interviews to identify actionable insights
- Recruiting: Identifying top-tier talent for a wide range of managed care roles
Advisory Board Management
Facilitation that bring together leading minds in oncology.
- Advisor recruiting
- Agenda development
- Moderating
- Summary reporting
Our Clients
Pharmaceutical and Biotech Companies
Whether determining the appropriate outcome metrics and standards for future access/reimbursement payer decisions or preparing for generic competition, ORM can help guide strategic choices within these companies to achieve revenue goals.
Payers
ORM provides a perspective on the oncology marketplace that is often difficult for payers to acquire. Our neutral point of view regarding various key stakeholders can better inform some payer decisions by helping them understand who prominent influencers are and how they operate.
GPOs and Distributors
Pharmaceutical companies often underutilize the GPO as a promotional channel. ORM facilitates the development of effective partnerships between distributors, their GPO membership and pharmaceutical companies to create synergy among various promotional initiatives within this channel.
Professional Associations
Professional associations play a critical role in aligning key oncology stakeholders at both the national and regional levels. ORM helps these organizations develop and implement strategies that not only achieve their goals for oncologists, but also support the best interests of payers, pharmaceutical companies and other oncology key players.
Oncologists
While ORM does not provide reimbursement services for individual practices (coverage, coding and billing), we do deliver data, analyses and recommendations to groups of practices that seek to improve how they work with other key stakeholders, such as pharmaceutical companies, payers and distributors.
Whether determining the appropriate outcome metrics and standards for future access/reimbursement payer decisions or preparing for generic competition, ORM can help guide strategic choices within these companies to achieve revenue goals.
Payers
ORM provides a perspective on the oncology marketplace that is often difficult for payers to acquire. Our neutral point of view regarding various key stakeholders can better inform some payer decisions by helping them understand who prominent influencers are and how they operate.
GPOs and Distributors
Pharmaceutical companies often underutilize the GPO as a promotional channel. ORM facilitates the development of effective partnerships between distributors, their GPO membership and pharmaceutical companies to create synergy among various promotional initiatives within this channel.
Professional Associations
Professional associations play a critical role in aligning key oncology stakeholders at both the national and regional levels. ORM helps these organizations develop and implement strategies that not only achieve their goals for oncologists, but also support the best interests of payers, pharmaceutical companies and other oncology key players.
Oncologists
While ORM does not provide reimbursement services for individual practices (coverage, coding and billing), we do deliver data, analyses and recommendations to groups of practices that seek to improve how they work with other key stakeholders, such as pharmaceutical companies, payers and distributors.
